CRDF Stock Analysis: Buy, Sell, or Hold?
CRDF - Cardiff Oncology, Inc. Common Stock
$1.30
0.03 (2.36%)
▲
5d:
+4.0%
30d:
-7.14%
90d:
-17.72%
BUY
HIGH Confidence
Analysis Updated: Jul 6, 2026 12:00 AM ET
Earnings: Aug 04, 2026
28d
Get Alerted When CRDF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CRDF shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: CRDF shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: CRDF is currently trading at $1.30, which is considered slightly low relative to its 30-day fair value range of $1.22 to $1.59.
Technical Outlook: Technically, CRDF is in a strong downtrend. Immediate support is located at $1.16, while resistance sits at $1.64.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.21 (+310.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CRDF is in a strong downtrend. Immediate support is located at $1.16, while resistance sits at $1.64.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.21 (+310.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.22 -
$1.59
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 310.6% below Wall St target ($5.21)
Trading Range Analysis
30-Day Trading Range
$1.22 -
$1.59
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.16
Resistance Level
$1.64
Current Trend
Strong Downtrend
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.56
Wall Street Target
$5.21
(+310.6%)
Revenue Growth (YoY)
-62.4%
Share & Embed Analysis
Last updated: July 06, 2026 4:17 PM ET
Data refreshes hourly during market hours. Next update: 5:17 PM
Data refreshes hourly during market hours. Next update: 5:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRDF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$435 | 60 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 62 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 60 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 66 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 56 HOLD |
